BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6290945)

  • 1. [Use of "active" vitamin D in uremic osteodystrophy].
    Tarchini R; Mioli V; Baldelli S; Figus S; Pacchiarotti P
    Minerva Med; 1982 Oct; 73(40):2775-8. PubMed ID: 6290945
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for the treatment of renal osteodystrophy in dialysis patients.
    Slatopolsky E
    Kidney Int Suppl; 1975 Jan; (2):253-5. PubMed ID: 169423
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of 1-alpha-hydroxyvitamin D 3 treatment of osteodystrophy in uremic patients treated with periodic hemodialysis].
    Palmieri P; Albertazzi A; Cappelli P; Di Paolo B
    G Clin Med; 1981 Jul; 62(7):443-60. PubMed ID: 7308629
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of vitamin D therapy on renal osteodystrophy in children (author's transl)].
    Bulla M; Stock GJ; Delling G; Hofmann H; Offermann G
    Klin Wochenschr; 1980 Mar; 58(5):237-47. PubMed ID: 6249957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal osteodystrophy: its pathogenesis, diagnosis and therapy].
    Kuska J
    Postepy Hig Med Dosw; 1977; 31(1):113-32. PubMed ID: 194231
    [No Abstract]   [Full Text] [Related]  

  • 6. Osteodystrophy of dialysed patients treated with vitamin D.
    Verberckmoes R; Bouillon R; Krempien B
    Proc Eur Dial Transplant Assoc; 1973; 10(0):217-26. PubMed ID: 4370246
    [No Abstract]   [Full Text] [Related]  

  • 7. Photonic densitometry for the diagnosis of the uremic osteodystrophy.
    Bordoni E; Baldelli S; Bibiano L; Bichi Secchi E; Lombardi M; Lombardo V; Micucci G; Procaccini G; Mioli V
    Life Support Syst; 1985; 3 Suppl 1():503-6. PubMed ID: 3870615
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal osteodystrophy in course of periodic dialysis for chronic uremia.
    Kim D; Bell NH; Bundesen W; Putong P; Simon NM; Walker C; Del Greco F
    Trans Am Soc Artif Intern Organs; 1968; 14():367-71. PubMed ID: 5701557
    [No Abstract]   [Full Text] [Related]  

  • 9. [Renal osteopathy].
    Binswanger U
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1683-90. PubMed ID: 1215956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of treatment with 1--alpha-hydroxyvitamin D3 in osteodystrophy in uremic patients undergoing periodical hemodialysis].
    Albertazzi A; Palmieri PF; Del Rosso G; Spisni C; Evangelista M
    Minerva Nefrol; 1980; 27(4):631-3. PubMed ID: 7254690
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of vitamin D analogs in renal osteodystrophy.
    Johnson WJ
    Semin Nephrol; 1986 Mar; 6(1):31-41. PubMed ID: 3037668
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal osteodystrophy in children: progress in its management.
    Chan JC
    Clin Pediatr (Phila); 1976 Nov; 15(11):996-1002. PubMed ID: 975714
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinico-morphological correlations in uremic osteodystrophy of patients with conservative and hemodialytic treatment with special regard to the ultrastructure].
    Bonucci E; Gherardi G; Mioni G; Castellani A; Cecchettin M; Cristinelli L; Migozzi G; Maiorca R; Maschio G; D'Angelo A; Ossi E; Lupo A; Valvo E
    Minerva Nefrol; 1975; 22(2-3):99-108. PubMed ID: 1226257
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized double blind study of 1, 25(OH)2D3 in dialysis patients.
    Maxwell DR; Benjamin DM; Donahay SL; Allen MK; Hamburger RJ; Luft FC; Kleit SA
    Proc Clin Dial Transplant Forum; 1977; 7():166-9. PubMed ID: 210446
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency].
    von Herrath D; Kraft D; Grigoleit HG; Schaefer K
    Dtsch Med Wochenschr; 1973 Jul; 98(28):1379-81. PubMed ID: 4197778
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effects of CaCO3 on renal osteodystrophy--comparison of patients with chronic renal failure in the predialytic stage and patients undergoing maintenance hemodialysis].
    Okada K; Kuno T; Yanai M; Maeda H; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1988 Aug; 30(8):1053-62. PubMed ID: 3244188
    [No Abstract]   [Full Text] [Related]  

  • 17. Azotaemic osteodystrophy-present position.
    Malhotra KK
    J Assoc Physicians India; 1978 Sep; 26(9):827-35. PubMed ID: 370080
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth in children treated with long-term dialysis. A study of 76 patients.
    Kleinknecht C; Broyer M; Gagnadoux MF; Martihenneberg C; Dartois AM; Kermanach C; Pouliquen M; Degoulet P; Usberti M; Roy MP
    Adv Nephrol Necker Hosp; 1980; 9():133-63. PubMed ID: 6250378
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth, renal osteodystrophy and vitamin D therapy in children with chronic renal failure.
    Hodson E
    Aust N Z J Med; 1981; 11(Suppl 1):38-9. PubMed ID: 6266378
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effects of estrogen on renal osteodystrophy in the female patients undergoing maintenance hemodialysis].
    Akino H; Saito A; Maeda S; Kitajima W; Okano M; Isomatsu Y; Muranaka K; Kanimoto Y; Shimizu Y; Kawada Y
    Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1129-36. PubMed ID: 3807045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.